drugset / Trial / NCT00802217
Oral Civamide Safety, Tolerability First in Human Study
Non-randomizedParallel-groupOpen-labelBasic science
Summary
Safety and pharmacokinetic first-time-in-human study of orally administered civamide in healthy subjects.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-06
- Completion
- 2009-07
Outcome
Outcome not reported
Stopped: “PK results demonstrated no systemic absorption”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zucapsaicin | Small molecule | 5 mg | Oral |
| Comparator | Zucapsaicin | Small molecule | 10 mg | Oral |
Indications
No indication recorded.